AusPAR: Fremanezumab

Australian Public Assessment Report

AusPAR

AusPAR: Fremanezumab [PDF, 746.94 KB]

AusPAR: Fremanezumab [Word, 2.51 MB]

Attachment: Product Information: Fremanezumab [PDF, 209.66 KB]

Attachment: Product Information: Fremanezumab [Word, 194.55 KB]

Device/Product Name

Ajovy

Active ingredients

Fremanezumab

AusPAR Date

18 December 2019

Published

24 January 2020

Submission Number

PM-2018-03494-1-1

Submission Type

New biological entity

Decision

Approved